Abstract: The present invention relates to pyrimidinones and pyridones and derivatives thereof, and pharmaceutically acceptable salts thereof. Also included is a method of treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic ? cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs.

Abstract: The present invention relates to compounds having the general formula or a pharmaceutically acceptable salt thereof, wherein R1 is a saturated or unsaturated 5-, 6- or 7-membered, ring containing 0, 1, 2 or 3 atoms selected from N, O and S, wherein the ring may be fused with a benzo group, and is substituted by 0, 1 or 2 oxo groups, and wherein R1 is additionally substituted; and R2 is a substituted C1-6alkyl. Also included is a method of prophylaxis or treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic ? cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs.

Abstract: Selected novel urea compounds are effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stoke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Abstract: Selected novel urea compounds are effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stoke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Abstract: Selected novel urea compounds are effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stoke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Abstract: Selected novel urea compounds are effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stoke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Abstract: Disclosed are processes for the isoberization of epoxyalkenes to dihydrofurans by contacting an epovyalkene with a catalyst comprising a quaternary organic onium iodide compounds, optionally deposited on a non-acidic support and/or in combination with a Lewis acid co-catalyst. The catalyst may comprise a supported catalyst, an unsupported catalyst or a solution of the catalytically-active components in an inert, organic solvent.

Abstract: Disclosed are processes for the isomerization of epoxyalkenes to dihydrofurans by contacting an epoxyalkene with a catalyst comprising a quaternary organic onium iodide compounds, optionally deposited on a non-acidic support and/or in combination with a Lewis acid co-catalyst. The catalyst may comprise a supported catalyst, an unsupported catalyst or a solution of the catalytically-active components in an inert, organic solvent.

Abstract: This invention provides polymers useful in coating compositions. The polymers are prepared via a free radical polymerization using ethylenically unsaturated monomers. The polymers of this invention possess pendant allylic groups which are capable of effecting free-radical flux when the compositions are applied to a substrate and exposed to oxygen. Coatings formed from preferred compositions possess superior solvent, print, and block resistance.

Abstract: Disclosed is a process for the preparation of 3,4-dichlorotetrahydrofuran, 3,4-dibromotetrahydrofuran, 2,3-dichlorotetrahydrofuran, and 2,3-dibromotetrahydrofuran by the reaction of 2,5- or 2,3-dihydrofuran with chlorine or bromine in the presence of a quaternary onium halide compound. The reaction preferably is carried out by the addition of the dihydrofuran and chlorine or bromine to an organic, halogenation solvent containing chlorine or bromine and the quaternary onium halide compound.

Abstract: Disclosed is a process for converting an iodine-free organotin (IV) compound resulting from the decomposition of an organotin (IV) iodide during the catalytic isomerization of .gamma.,.delta.-epoxyalkenes to 2,5-dihydrofurans to the corresponding, catalytically active organotin (IV) iodide by intimately contacting a catalyst mixture comprising (i) an organotin (IV) iodide, (ii) an iodine-free organotin (IV) compound resulting from the decomposition of the organotin (IV) iodide of component (i), and (iii) a solvent selected from hydrocarbons and chlorocarbons with aqueous hydrogen iodide.

Abstract: Disclosed are novel polyether compounds obtained by the reaction or polymerization of 3,4-epoxy-1-butene in the presence of an onium iodide compound such as an ammonium or phosphonium iodide, an organotin compound such as a trihydrocarbyltin iodide, and a nucleophilic initiator compound. The polyether compounds comprise n units of residue (1) and m units of residue (2), wherein the total value of n+m is 2 to 70, m/(n+m) is greater than 0.75 and up to 0.

Abstract: Polyether polymers obtained by the reaction or polymerization of 3,4-epoxy-1-butene in the presence of an onium iodide compound such as an ammonium or phosphonium iodide, an organotin compound such as a trihydrocarbyltin iodide, and a nucleophilic hydroxyl initiator compound. The polyether polymers comprise n units of residue (1) and m units of residue (2), wherein the total value of n+m is 2 to 70, m/(n+m) is greater than 0.75 and up to 0.

Abstract: Disclosed is a process for the preparation of 3,4-dichloro and 3,4-dibromo-1,2-epoxybutane by the reaction of 3,4-epoxy-1-butene with chlorine or bromine in the presence of a catalytic amount of a tertiary amine or a hydrohalide of a primary, secondary or tertiary amine. The reaction preferably is carried out by the addition of 3,4-epoxy-1-butene and chlorine or bromine to an organic, halogenation solvent containing chlorine or bromine and tertiary amine or amine hydrohalide catalyst.

Abstract: Disclosed is a process for the preparation of 3,4-dichloro- and 3,4-dibromo-1,2-epoxybutane by the reaction of 3,4-epoxy-1-butane with chlorine or bromine in the presence of a quaternary ammonium or phosphonium halide compound. The reaction preferably is carried out by the addition of 3,4-epoxy-1-butane and chlorine or bromine to an organic, halogenation solvent containing chlorine or bromine and the quaternary compound.